Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host diseaseDaniel H Fowler, Jason Foley, Jeannie Whit-Shan Hou, et al.Experimental Hematology|May 22, 2013
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemiaBrian C Shaffer, Marko Modric, Maryalice Stetler-Stevenson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantationRachel B Salit, Daniel H Fowler, Robert M Dean, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejectionJacopo Mariotti, Jason Foley, Unsu Jung, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomasMichael R Bishop, Jeannie Whit-Shan Hou, Wyndham H Wilson, et al.Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.Pageof 12